Skip to page content

Biomedical Research

Featured

Report
Technological Approaches to Human Performance Enhancement
Human performance enhancement (HPE) will have implications for military and intelligence operations. A variety of HPE could be of potential military and intelligence operational value. What are some approaches to HPE?
Nov 23, 2021
Commentary
Global Health Data Sharing: The Case of China and the Two Coronavirus Pandemics
Tensions over the coronavirus seem to be prompting China to isolate itself in terms of data sharing. But the first coronavirus pandemic in 2003 actually helped open China to health collaborations with other countries. World leaders may be doing their citizens a disservice when they allow toxic geopolitics to undercut trust and international collaborations that took decades to build.
Nov 22, 2021

Explore Biomedical Research

Commentary
New Clinical Outcome Assessments Could Improve Treatment for Parkinson's
The prevalence of Parkinson's disease has doubled over the last 25 years, and over 8.5 million people are living with the disease worldwide, but treatment options are limited. The development of new clinical outcome assessments could lead to new treatments for the disease.
Apr 25, 2023
Report
Clinical Outcome Assessments and Digital Health Technologies Supporting Clinical Trial Endpoints in Early Parkinson's Disease: Roundtable Proceedings and Roadmap for Research
This document summarizes the proceedings of an event held to discuss challenges in clinical outcome assessment development for treatments in early Parkinson's disease and to identify priorities for the field and opportunities for collaboration.
Apr 24, 2023
Report
Impacts of increasing requirements for research and development (R&D) cost transparency: Literature review
A literature review shows that increasing the transparency of the research and development costs of new medicines is much discussed. But there is no evidence of the impact this would have on medicines' prices or the rate of innovation.
Mar 31, 2023
Blog
RAND President and CEO Presenting to House Permanent Select Committee on Intelligence
RAND President and CEO Jason Matheny appeared on February 28, 2023, before the House Permanent Select Committee on Intelligence. His remarks covered advances in synthetic biology and artificial intelligence and their potential impact on national security.
Feb 28, 2023
Commentary
Brain and Machine Confluence Requires Multi-Sectoral Regulation to Maximize Gains
As the commercialization of brain-computer interface technology expands, it would be prudent for international policymakers to consider how this technology should be regulated, in order to reap its benefits and minimize its risks.
Feb 15, 2023
Commentary
Improving How Medicines R&D Is Financed Could Support Innovation and Benefits for Patients
Tackling chronic and infectious diseases depends to a large extent on the ability to develop innovative and affordable medicines that are available to patients in need. Policymakers will need to tackle challenges from multiple angles to avoid reducing barriers in one area at the expense of exacerbating challenges in another.
Aug 25, 2022
Dissertation
Gaps between Medical Cannabis Research and Policy
Examines what is known about the therapeutic efficacy of cannabis products, the degree to which patients buy dispensary products in a manner that is consistent with clinical research, and what factors may be driving clinically inconsistent purchases.
Aug 24, 2022
Blog
U.S. Labor Market, 988 Hotline, Firearm Homicides: RAND Weekly Recap
This weekly recap focuses on the U.S. economy’s uneven pandemic recovery, a new national mental health hotline, firearm homicides, and more.
Jul 22, 2022
Commentary
Doubling NIH Funding for Women's Health Would Yield Substantial Return on Investment
The scientific evidence base generally is biased toward the male body as a result of a long history of generous funding for diseases that predominantly affect men and underfunding for those that predominantly affect women. But the cost of the science pales in comparison to the price we continue to pay for what we don't know about caring for women.
Jul 8, 2022
Commentary
Diversity, Equality, and Inclusion in Health Care Innovation
For health care innovations to have the fairest and broadest possible benefit to society, efforts could be made to attend to all stages of the innovation pathway to identify opportunities to mitigate biases through diversity, equality, and inclusion.
Jul 6, 2022
Commentary
Microbiome-Based Health and Wellness Innovation
Microbiome research and development may lead to an increasing number of therapeutic and well-being breakthroughs. But regulating microbiota-related products poses a challenge that could require innovative approaches.
Jul 6, 2022
Commentary
Setting the Direction for the UK's Research Relationship with China
UK-China research has the potential to sustain the very forms of academic excellence that a more-isolationist approach sets out to protect, while also raising the possibility of bridge-building and tackling shared problems. For this to become a reality, knowledge and understanding of China in the United Kingdom must improve.
Jun 30, 2022
Journal Article
The Financial Ecosystem of Pharmaceutical R&D: An Evidence Base to Inform Further Dialogue
This study's overarching conclusion is that a drug's expected financial return ultimately determines whether it is developed up to launch.
Jun 24, 2022
News Release
Don't Cut Research Ties with China, Say UK Academics
A new study from the not-for-profit research institute RAND Europe involving more than 80 UK-based academics from a range of disciplines and institutions finds a resounding appetite for continued collaboration with Chinese colleagues, despite acknowledged tension over security concerns.
Jun 22, 2022
Multimedia
The Economic Benefits of Investing in Women's Health Research
RAND senior sociologist Chloe Bird explains that the benefits of investing in women's health research aren't limited to women's health, but rather include the potential for enormous economic gains.
Mar 7, 2022
Commentary
Underfunding of Research in Women's Health Issues Is the Biggest Missed Opportunity in Health Care
For far too long, the medical sciences have treated men and women as interchangeable subjects, favoring men's health for funding and the male body for study. This approach creates a problem, not just for women but for everyone. Not only does it miss a large and critical slice of the population, it leaves an unknown amount of science unexplored.
Feb 11, 2022
Journal Article
Return of Genomic Results Does Not Motivate Intent to Participate in Research for All: Perspectives Across 22 Countries
The aim of this study was to determine how attitudes toward the return of genomic research results vary internationally.
Feb 8, 2022
Journal Article
Progress Report: AMR Industry Alliance 2021 Survey
An analysis of AMR Industry Alliance contributions to the fight against antimicrobial resistance.
Feb 1, 2022

1
2
3
4
5
6
Next

RAND Topic:
Biomedical Research

Topic Synonyms:
Medical Research

Research conducted by

Researcher Spotlight

Denis Agniel

Full Statistician

Denis Agniel is a statistician at the RAND Corporation. He is interested in and maintains active research in a wide array of topics in health and health policy, including health equity, substance use, health services research, genomics, infectious diseases, and quality measurement. He has…
Anna Blundell

Analyst

Anna Blundell (she/her) is an analyst at the RAND Corporation. Working within the area of health and wellbeing at RAND Europe, her research interests include mental health, biomedical research, substance use, health inequalities and patient experience. Before joining RAND, Blundell worked as a…

Explore Our People »